Morphing VC into the Buyout Game
Venture capitalists are avoiding health care, in part because they make more money elsewhere, in part because their funds are too large for many of the start-ups looking for capital. One alternative: buyouts, on the model of Warburg's acquisition of American Medical Systems.
You may also be interested in...
Data presented at AAAI meeting show reduced annualized asthma exacerbation rates across all patient populations, but doctors are unlikely to switch patients served well by existing biologics.
The RNA drug’s accelerated approval brings Sarepta’s exon-skipping market share to nearly 30%.
Limiting interactions to two-dimensional settings will hinder collaboration, innovation and the mentoring of younger employees, Merck & Co. CEO Kenneth Frazier says. Frazier, who will retire in June, is looking forward to returning to public service but says "politics with a capital P is not my thing."